Cargando…
CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets
Sarcomas represent one of the most challenging tumor types to treat due to their diverse nature and our incomplete understanding of their underlying biology. Recent work suggests cyclin-dependent kinase (CDK) pathway activation is a powerful driver of sarcomagenesis. CDK proteins participate in nume...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215455/ https://www.ncbi.nlm.nih.gov/pubmed/32344731 http://dx.doi.org/10.3390/ijms21083018 |